Recent market analysis has indicated a notable surge in the global oscillating positive expiratory pressure (OPEP) device market, which is expected to reach a valuation of USD 151.30 million by 2024 and is projected to grow to USD 263.40 million by 2034. This growth reflects a steady Compound Annual Growth Rate (CAGR) of 5.70% between 2024 and 2034, driven by increasing adoption and prevalence of these devices in respiratory therapy.
OPEP devices have garnered significant attention due to their effectiveness in managing respiratory disorders such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and cystic fibrosis. These devices play a crucial role in enhancing lung function and improving the quality of life for patients suffering from pulmonary conditions.
Request A Report Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-3397
The adoption of OPEP devices with telehealth and digital health platforms creates an opportunity for market growth. Remote monitoring of the patients, data acquisition, and virtual medical consultations augment medical care and treatment results. The oscillating positive expiratory pressure (OPEP) devices producers who invest in technology integration find it to be a thriving market.
The procedure of regulatory approval for OPEP devices, is lengthy and strict. The hindrance in securing regulatory approvals impedes the launch of new products, constraining the growth opportunities of OPEP devices producers.
Regional Outlook:
North America and Europe garner a significant OPEP device market share. East Asia market projects lucrative growth in the global OPEP devices market from 2024 to 2034. The oscillating positive expiratory pressure device market growth is augmented by soaring local producers prompting elevated product availability at economical prices.
The widespread chronic obstructive pulmonary disease (COPD) is escalating owing to the strengthening smoking population in China and the elderly population in Japan with respiratory illnesses. Low consciousness regarding oscillating positive expiratory pressure devices among healthcare practitioners and patients inhibits the growth of the OPEP device market.
“The oscillating positive expiratory pressure (OPEP) device market witnesses a steady growth escalated by surging consciousness of respiratory health, amplifying the occurrence of respiratory diseases, and medical system infrastructure innovations. Demand for respiratory therapy solutions soars the OPEP device market expansion with remarkable investment potential.”, comments an analyst at FMI.
Key Takeaways:
- The COPD sector in the indication category to clutch a share of 33.70% in 2024.
- In the product type category, the mouthpiece PEP devices sector to possess a market share of 96.80% in 2024.
- Italy OPEP device market imply augmentation at a CAGR of 5.20% between 2024 and 2034.
- Germany oscillating positive expiratory pressure device market indicates a CAGR of 5.60% through 2034.
- France oscillating positive expiratory pressure device market indicates a CAGR of 5.00% through 2034.
- Spain sales of OPEP device indicate a CAGR of 4.60% through 2034.
- The United Kingdom oscillating positive expiratory pressure (OPEP) device market reflects expansion between 2024 and 2034 at a CAGR of 5.40%.
- From 2024 to 2034, Russia OPEP device industry equates at a CAGR of 4.10%.
- Through 2034, BENELUX oscillating positive expiratory pressure (OPEP) device industry show escalation at a CAGR of 4.60%.
- China oscillating positive expiratory pressure (OPEP) device market exhibit upsurge at CAGR of 6.00% between 2024 and 2034.
- Between 2024 and 2034, the United States oscillating positive expiratory pressure device industry imply growth at a CAGR of 5.40%.
- From 2024 to 2034, Russia oscillating positive expiratory pressure (OPEP) device market equates at a CAGR of 4.10%.
- Japan OPEP device industry implies expansion at a CAGR of 5.60% through 2034.
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-3397
Competitive Landscape:
The oscillating positive expiratory pressure (OPEP) device manufacturers are competitive, with the presence of few vendors. These oscillating positive expiratory pressure device market producers are involved in several strategic partnerships. The new launches and purchases intensify the OPEP device vendor’s scheme to gain from the market share and secure a notable share.
Noteworthy Developments:
- Smith’s Medical debuted the acapella choice blue vibratory PEP therapy system in April 2021. Acapella is made to remove secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), lung disease with secretory troubles, and atelectasis patients.
- In January 2021, AirPhysio was signified for use as a Positive Expiratory Pressure (PEP) Device and earned approval from the United States FDA.
Essential Oscillating Positive Expiratory Pressure (OPEP) Device Manufacturers:
- Smith’s Medical, Inc.
- Allergan plc
- Monaghan Medical Corporation & Trudell Medical International
- Others
- PARI GmbH
- WyMedical Pty Ltd
- R. Cegla GmbH & Co. KG
- D-R BURTON HEALTHCARE
- AirPhysio
- Medica Holdings, LLC.
Key Segments:
By Product Type:
- Face Mask PEP Devices
- Mouthpiece PEP Devices
- Bottle PEP Devices
By Indication:
- COPD
- Asthma
- Atelectasis
- Bronchitis
- Bronchiectasis
- Cystic Fibrosis
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Request Full Report Now: https://www.futuremarketinsights.com/checkout/3397
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
